Skipping the Drip: Intravenous Proton Pump Inhibitor Bolus Therapy Leads to Poor Outcomes in High-Risk Bleeding

Background and Aim The aim of this study was to evaluate the impact of a change in our institute’s protocol from continuous intravenous (IV) proton pump inhibitor (PPI) therapy to bolus IV PPI therapy for the treatment of peptic ulcer-related bleeding on patient outcomes. Current guidelines recommen...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Raja Samir, Hadi, Yousaf B, Chima, Noor, Kupec, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325381/
https://www.ncbi.nlm.nih.gov/pubmed/32617233
http://dx.doi.org/10.7759/cureus.8362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325381/
https://www.ncbi.nlm.nih.gov/pubmed/32617233
http://dx.doi.org/10.7759/cureus.8362

Ejemplares similares